HER2.M+ Trademark

Trademark Overview

On Monday, January 20, 2025, a trademark application was filed for HER2.M+ with the United States Patent and Trademark Office. The USPTO has given the HER2.M+ trademark a serial number of 99012962. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, January 20, 2025. This trademark is owned by Boehringer Ingelheim International GmbH. The HER2.M+ trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Provision of medical research information and scientific information in the field of oncology
her2.m+

General Information

Serial Number99012962
Word MarkHER2.M+
Filing DateMonday, January 20, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, January 20, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesProvision of medical research information and scientific information in the field of oncology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 20, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressIngelheim 55218
DE

Trademark Events

Event DateEvent Description
Monday, January 20, 2025NEW APPLICATION ENTERED
Monday, January 20, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

information field oncology scientific provision research medical